Explore / Clinical trial
Clinical trial

Repeated Intranasal Esketamine Plus Almond Therapy in Patients With Treatment Resistant Depression

Zylorion HealthTerminatedPhase 2Started Oct 13, 20226 enrolledCanadaNCT05323019

Abstract

To examine the efficacy of Almond Therapy compared to Treatment as Usual when used in addition to an approved version of intranasal esketamine.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetamineDepression

Keywords

Treatment Resistant Major Depressive Disorder

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.